| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,695,542 | 2,707,573 | 2,851,680 | 2,615,515 | | Cost of Revenue | 1,521,879 | 2,172,781 | 2,949,834 | 1,175,222 | | | Gross Profit | 1,173,663 | 534,792 | (98,154) | 1,440,293 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 594,151 | (23,918) | (755,279) | 986,364 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 208,715 | 205,867 | 209,131 | 194,093 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 370,797 | 352,843 | 447,994 | 259,836 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 20,579 | 50,552 | 8,970 | 24,870 | | Earnings Before Interest And Taxes | 391,376 | 401,050 | 459,309 | 284,706 | | Interest Expense | 131,575 | 152,252 | 114,858 | 124,127 | | Income Before Tax | 259,801 | 248,798 | 344,451 | 160,579 | | Income Tax Expense | 87,125 | 85,240 | 121,757 | 55,105 | | Minority Interest |
-
| (510) | 510 |
-
| | | | Net Income From Continuing Ops | 175,818 | 163,558 | 222,694 | 105,474 | | | Non-recurring Events | | Discontinued Operations | (1,751) | 518 | 94 | 99 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 174,067 | 164,076 | 222,788 | 105,573 | | Preferred Stock And Other Adjustments | (1,060) | (1,061) | (1,060) | (1,060) | | | Net Income Applicable To Common Shares | $173,007 | $163,015 | $221,728 | $104,513 |
|
0.45% Nasdaq 
0.20%
Income Statement
